Jifeng Ma1, Vanita Sahasranaman2, Russell S Kirby3, Timothy Boaz4. 1. Florida Medicaid Drug Therapy Management Program for Behavioral Health, Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA. jifengma@usf.edu. 2. Florida Medicaid Drug Therapy Management Program for Behavioral Health, Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA. 3. Strategic Area Lead for Population Health Science, College of Public Health, University of South Florida, Tampa, FL, USA. 4. Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA.
Abstract
OBJECTIVE: Determine odds ratios for neonatal abstinence syndrome (NAS) and neonatal intensive care unit (NICU) admissions for babies born to women associated with severe mental illness (SMI) and gestational opioid use. STUDY DESIGN: A retrospective pharmacoepidemiologic study using Medicaid data included 17,130 mothers with and 170,430 mothers without SMI, and their babies. Odds ratios for NAS and NICU admissions among babies born to mothers associated with SMI diagnoses and associated with varying degrees of gestational opioid use were determined using logistic regression. RESULTS: The adjusted odds ratio for a baby in the methadone or buprenorphine group having NAS was 168.93 [95% confidence interval (CI) 148.78-191.71, P < 0.001] and was 9.64 (95% CI 8.74-10.65, P < 0.001) for NICU admissions compared to babies with no opioid exposure. CONCLUSIONS: Chronicity of prescription maternal opioid use was the strongest factor associated with NAS and NICU admissions.
OBJECTIVE: Determine odds ratios for neonatal abstinence syndrome (NAS) and neonatal intensive care unit (NICU) admissions for babies born to women associated with severe mental illness (SMI) and gestational opioid use. STUDY DESIGN: A retrospective pharmacoepidemiologic study using Medicaid data included 17,130 mothers with and 170,430 mothers without SMI, and their babies. Odds ratios for NAS and NICU admissions among babies born to mothers associated with SMI diagnoses and associated with varying degrees of gestational opioid use were determined using logistic regression. RESULTS: The adjusted odds ratio for a baby in the methadone or buprenorphine group having NAS was 168.93 [95% confidence interval (CI) 148.78-191.71, P < 0.001] and was 9.64 (95% CI 8.74-10.65, P < 0.001) for NICU admissions compared to babies with no opioid exposure. CONCLUSIONS: Chronicity of prescription maternal opioid use was the strongest factor associated with NAS and NICU admissions.
Authors: Alexander Jarde; Michelle Morais; Dawn Kingston; Rebecca Giallo; Glenda M MacQueen; Lucy Giglia; Joseph Beyene; Yi Wang; Sarah D McDonald Journal: JAMA Psychiatry Date: 2016-08-01 Impact factor: 21.596
Authors: Hendrée E Jones; Gabriele Fischer; Sarah H Heil; Karol Kaltenbach; Peter R Martin; Mara G Coyle; Peter Selby; Susan M Stine; Kevin E O'Grady; Amelia M Arria Journal: Addiction Date: 2012-11 Impact factor: 6.526
Authors: Elisha M Wachman; Marie J Hayes; Mark S Brown; Jonathan Paul; Karen Harvey-Wilkes; Norma Terrin; Gordon S Huggins; Jacob V Aranda; Jonathan M Davis Journal: JAMA Date: 2013-05-01 Impact factor: 56.272